UNSPSC 85373302: Diagnosis of thrombotic microangiopathy

This classification denotes the group of activities that yields a diagnosis of Thrombotic microangiopathy. Thrombotic microangiopathy is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code M31. 1

UNSPSC 85373302 Diagnosis of thrombotic microangiopathy, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The three most recent opportunities posted under this code involve diagnostic imaging systems architecture (San Mateo Medical Center's PACS procurement), special education contracted services (Birdville Independent School District), and temporary health professional staffing qualification pools (Santa Clara Health System) — none of which concern thrombotic microangiopathy diagnosis or related hematologic services. The code appears to capture only the San Mateo Medical Center PACS solicitation as genuinely relevant to imaging-based diagnostics, while the school district and health system opportunities represent category misclassification or inconsistent tagging by the issuing bodies.

Recent activity spans California and Texas, with San Mateo County (SMMC) issuing an RFP for enterprise diagnostic imaging infrastructure due October 21, 2026, requiring EPIC integration, 99.9% uptime, and data migration from legacy ScImage systems; Birdville ISD issuing a competitive sealed proposal for special education services (audiology, speech therapy, occupational therapy, and related disciplines) due October 21, 2026; and Santa Clara Health System issuing a non-exclusive multiple-award qualification vehicle for temporary ancillary health professional staffing across 13 categories including diagnostic imaging/radiology, due October 7, 2026. The code shows no substantive recent procurement volume tied to laboratory or hematologic diagnosis of thrombotic microangiopathy. Buyers seeking contracts in this commodity should verify code application during pre-bid or question cycles, as the current tagging pattern does not reliably identify demand in this clinical specialty.